| Seasonal influenza vaccination in patients with COPD: a systematic literature review R Bekkat-Berkani, T Wilkinson, P Buchy, G Dos Santos, D Stefanidis, ... BMC pulmonary medicine 17, 1-15, 2017 | 166 | 2017 |
| Maternal immunization: where are we now and how to move forward? I Vojtek, I Dieussaert, TM Doherty, V Franck, L Hanssens, J Miller, ... Annals of medicine 50 (3), 193-208, 2018 | 144 | 2018 |
| Vaccines against meningococcal diseases M Pizza, R Bekkat-Berkani, R Rappuoli Microorganisms 8 (10), 1521, 2020 | 109 | 2020 |
| Safety of AS03-adjuvanted influenza vaccines: A review of the evidence C Cohet, R van der Most, V Bauchau, R Bekkat-Berkani, TM Doherty, ... Vaccine 37 (23), 3006-3021, 2019 | 88 | 2019 |
| Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review G Dos Santos, H Tahrat, R Bekkat-Berkani Human Vaccines & Immunotherapeutics 14 (8), 1853-1866, 2018 | 79 | 2018 |
| A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control R Ray, G Dos Santos, PO Buck, C Claeys, G Matias, BL Innis, ... Human vaccines & immunotherapeutics 13 (7), 1640-1652, 2017 | 68 | 2017 |
| Influenza: can we cope better with the unpredictable? G Dos Santos, E Neumeier, R Bekkat-Berkani Human vaccines & immunotherapeutics 12 (3), 699-708, 2016 | 48 | 2016 |
| Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect Y Ruiz García, WY Sohn, KL Seib, MK Taha, JA Vázquez, APS de Lemos, ... npj Vaccines 6 (1), 130, 2021 | 36 | 2021 |
| Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination F Martinón-Torres, A Banzhoff, C Azzari, P De Wals, R Marlow, H Marshall, ... Journal of Infection 83 (1), 17-26, 2021 | 33 | 2021 |
| Methods to evaluate serogroup B meningococcal vaccines: from predictions to real-world evidence R Borrow, MK Taha, MM Giuliani, M Pizza, A Banzhoff, R Bekkat-Berkani Journal of Infection 81 (6), 862-872, 2020 | 33 | 2020 |
| Evolving strategies for meningococcal vaccination in Europe: overview and key determinants for current and future considerations F Martinón-Torres, MK Taha, M Knuf, V Abbing-Karahagopian, ... Pathogens and Global Health 116 (2), 85-98, 2022 | 27 | 2022 |
| Understanding the unique characteristics of seasonal influenza illness to improve vaccine uptake in the US R Bekkat-Berkani, L Romano-Mazzotti Vaccine 36 (48), 7276-7285, 2018 | 24 | 2018 |
| Evidence update: GlaxoSmithKline’s inactivated quadrivalent influenza vaccines R Bekkat-Berkani, R Ray, VK Jain, V Chandrasekaran, BL Innis Expert Review of Vaccines 15 (2), 201-214, 2016 | 24 | 2016 |
| Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease MK Taha, F Martinon-Torres, R Köllges, P Bonanni, MAP Safadi, R Booy, ... Expert review of vaccines 21 (5), 659-674, 2022 | 22 | 2022 |
| Range of invasive meningococcal disease sequelae and health economic application–a systematic and clinical review J Shen, N Begum, Y Ruiz-Garcia, F Martinon-Torres, R Bekkat-Berkani, ... BMC Public Health 22 (1), 1078, 2022 | 20 | 2022 |
| Meningococcal disease outbreaks: a moving target and a case for routine preventative vaccination L Soumahoro, V Abitbol, N Vicic, R Bekkat-Berkani, MAP Safadi Infectious Diseases and Therapy 10, 1949-1988, 2021 | 19 | 2021 |
| Real-world implementation of 4-component meningococcal serogroup B vaccine (4CMenB): implications for clinical practices WY Sohn, H Tahrat, P Novy, R Bekkat-Berkani Expert Review of Vaccines 21 (3), 325-335, 2022 | 16 | 2022 |
| Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: an application to England E Beck, J Klint, S Garcia, V Abbing, V Abitbol, O Akerborg, L Argante, ... Vaccine 38 (47), 7558-7568, 2020 | 11 | 2020 |
| A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB) GS Marshall, V Abbing-Karahagopian, HS Marshall, S Cenci, JH Conway, ... Expert Review of Vaccines 22 (1), 530-544, 2023 | 8 | 2023 |
| Public health perspective of a pentavalent meningococcal vaccine combining antigens of MenACWY-CRM and 4CMenB R Bekkat-Berkani, E Fragapane, S Preiss, R Rappuoli, WY Sohn, ... Journal of Infection 85 (5), 481-491, 2022 | 8 | 2022 |
